Sponsors

Panel for interfering substances

Firefly Scientific has launched its OptiChallenge Inhibition Panel for use in evaluating the performance of an assay in the presence of interfering substances.

The sevenmember panel is the very first to provide quantified amounts of commonly recognised inhibitors. The panel members represent elevated levels of inhibitory substances encountered routinely in the normal patient population.

Interfering substances such as heparin, lipids, bilirubin and haemolysed plasma are found commonly in patient samples. At minimal levels, these substances do not interfere with assay results. However, when levels become elevated due to the effect of lifestyle or medications, these substances can hinder the amplification of nucleic acid assays. Studies show that 12.5% of incorrect and delayed test results affect patient health.

The OptiChallenge Inhibition Panel allows laboratories to identify limitations in testing due to the presence of interfering substances and enables appropriate actions to be taken.

www.fireflyscientific.co.uk

Latest Issues

London GI Pathology Update 2026

Barbican Centre, London; and online.
28 April - 1 May

Specialist Staining – Technical Issues Master Class

The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
28 April, 2026

Diagnostic Cytopathology – Beginners Master Class

The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
5 May, 2026

Power to Disrupt : Leaders in POCT Diagnostics

Leonardo Royal Hotel, 245 Broad St, Birmingham, B1 2HQ
5 May, 2026

Diagnostic Cytopathology – Intermediate Master Class

The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
6 May, 2026